Solid Tumor Cancer Treatment Market Is Predicted To Hit US$ 424.6 Bn By 2027 | Credence Research
The global market for solid tumor cancer treatment was estimated at US$ 121.3 billion in 2018 and is expected to reach US$ 424.6 billion by 2027, expanding at a CAGR of 15.0 percent from 2019 to 2027.
SANJOSE, United States – August 7, 2019 /MarketersMedia/ —
The latest market report published by Credence Research, Inc. “Global Solid Tumor Cancer Treatment Market – Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global solid tumor cancer treatment market was valued at US$ 121.3 Bn in 2018, and is expected to reach US$ 424.6 Bn by 2027, expanding at a CAGR of 15.0% from 2019 to 2027.
Market Insights
As per the research findings of the International Agency for Research (IARC) on Cancer in association with World Health Organization (WHO) in 2018, approximately 18.1 million new cases of cases were reported. They also claim that 1 in 6 women and 1 in 5 men are likely to develop cancer during their lifetime.
Browse the full report Solid Tumor Cancer Treatment Market – Growth, Future Prospects, Competitive Analysis, 2019 – 2027 report at https://www.credenceresearch.com/report/solid-tumor-cancer-treatment-market
Breast cancer is dominating the indication segment for solid tumor cancer treatment market. The major factors hold responsible for its rising prevalence in the female population worldwide is hormonal imbalance during the menstrual cycle, unhealthy lifestyle and low or no breastfeeding during the lifetime. A significant spurt is expected to be seen in the prevalence rate of lung cancer throughout the globe on account of the significant rise in the number of smokers and rising air pollution at an alarming rate.
Chemotherapy is currently the largest market in the therapy segment for solid tumor cancer treatment. Availability of its generic version at affordable cost increases its popularity in treating cancer. It is used alone or in combination for treating tumors in different parts of the human body. Biological molecules such as immunotherapy and targeted therapy are gaining prominence in cancer treatment on account of its excellent pharmacodynamic features ensuring minimal side effects and maximum therapeutic efficacy. Favorable reimbursement scenario further increases its demand in cancer treatment.
North America is presently holding 33.6% market share in the regional segment for solid tumor cancer treatment market. According to the research citing brought forward by Center for Disease Control and Prevention, in a span of 10 years form 2010-2020, in the United States approximately 1 million cases will be reported in men population and 900,000 in female population annually. Europe accounts for 30.2% market share on account of the supportive regulatory environment provided by the European Medical Agency (EMA) for the development and sale of medicines used in the treatment of solid tumor cancer. Asia Pacific with a share of 19.5% is keen to register magnificent growth in the near future owing to the rising public health awareness regarding cancer and its treatment and developing healthcare infrastructure.
Pharmaceutical companies spearheading the solid tumor cancer treatment market are AstraZeneca, Plc., Amgen, Inc., B. Braun Melsungen AG, Bristol Myers Squibb & Company, Eli Lilly & Company, F.Hoffman La-Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc. and Olympus Medical Systems.
Key Market Movements:
Significant rise in the diagnosis of new cases of cancer worldwide
Recent approval of biologics exhibiting excellent pharmacodynamic properties with minimal side effects
Affordable reimbursement scenario for medicines employed for the treatment of solid tumor cancer
Report Scope by Segments
By Indication (2017–2027; US$ Bn)
Breast Cancer
Cervical Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others
By Therapy (2017–2027; US$ Bn)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormone Therapy
Surgical Procedures
Request Free Sample: https://www.credenceresearch.com/sample-request/59822
ToC:
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
…………
Chapter 3. Solid Tumor Cancer Treatment Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global Solid Tumor Cancer Treatment Market, by Key Players, 2018
Chapter 4. Global Solid Tumor Cancer Treatment Market, by Indication
4.1. Overview
4.2. Breast Cancer
4.3. Cervical Cancer
4.4. Colorectal Cancer
4.5. Lung Cancer
4.6. Prostate Cancer
4.7. Others (Brain Tumor, Pancreatic Cancer etc.)
Chapter 5. Global Solid Tumor Cancer Treatment Market, by Therapy
5.1. Chemotherapy
5.2. Targeted Therapy
5.3. Immunotherapy
5.4. Hormone Therapy
5.5. Surgical Procedures
Chapter 6. Global Solid Tumor Cancer Treatment Market, by Geography
…………..
Chapter 7. Company Profiles
7.1. AstraZeneca, Plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Amgen, Inc.
7.3. B. Braun Melsungen AG
7.4. Bristol Myers Squibb & Company
7.5. Eli Lilly & Company
7.6. F.Hoffman La-Roche Ltd.
7.7. Merck & Co., Inc.
7.8. Novartis
7.9. Pfizer, Inc.
7.10. Olympus Medical Systems
…………toc continued
Request Free Sample: https://www.credenceresearch.com/sample-request/59822
Key questions answered in this report
Which are the major biopharmaceutical companies actively providing medicines for the treatment of solid tumor cancer?
Which organic and inorganic market growth strategies are being considered for performing market assessment?
What is the disease etiology and prevalence rate of common types of cancer worldwide?
What does biologics comprise of and what will be its CAGR during the growth period?
What is the market size in developed regions such as North America and Europe?
Browse the full report Solid Tumor Cancer Treatment Market – Growth, Future Prospects, Competitive Analysis, 2019 – 2027 report at https://www.credenceresearch.com/report/solid-tumor-cancer-treatment-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research Inc.
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com
Source: MarketersMedia
Release ID: 88905429
Copyright © 1999-2013 SproutNews.com
